Montalbán-Hernández, K.; Cantero-Cid, R.; Lozano-Rodríguez, R.; Pascual-Iglesias, A.; Avendaño-Ortiz, J.; Casalvilla-Dueñas, J.C.; Bonel Pérez, G.C.; Guevara, J.; Marcano, C.; Barragán, C.;
et al. Soluble SIGLEC5: A New Prognosis Marker in Colorectal Cancer Patients. Cancers 2021, 13, 3896.
https://doi.org/10.3390/cancers13153896
AMA Style
Montalbán-Hernández K, Cantero-Cid R, Lozano-Rodríguez R, Pascual-Iglesias A, Avendaño-Ortiz J, Casalvilla-Dueñas JC, Bonel Pérez GC, Guevara J, Marcano C, Barragán C,
et al. Soluble SIGLEC5: A New Prognosis Marker in Colorectal Cancer Patients. Cancers. 2021; 13(15):3896.
https://doi.org/10.3390/cancers13153896
Chicago/Turabian Style
Montalbán-Hernández, Karla, Ramón Cantero-Cid, Roberto Lozano-Rodríguez, Alejandro Pascual-Iglesias, José Avendaño-Ortiz, José Carlos Casalvilla-Dueñas, Gloria Cristina Bonel Pérez, Jenny Guevara, Cristóbal Marcano, Cristina Barragán,
and et al. 2021. "Soluble SIGLEC5: A New Prognosis Marker in Colorectal Cancer Patients" Cancers 13, no. 15: 3896.
https://doi.org/10.3390/cancers13153896
APA Style
Montalbán-Hernández, K., Cantero-Cid, R., Lozano-Rodríguez, R., Pascual-Iglesias, A., Avendaño-Ortiz, J., Casalvilla-Dueñas, J. C., Bonel Pérez, G. C., Guevara, J., Marcano, C., Barragán, C., Valentín, J., del Fresno, C., Aguirre, L. A., & López Collazo, E.
(2021). Soluble SIGLEC5: A New Prognosis Marker in Colorectal Cancer Patients. Cancers, 13(15), 3896.
https://doi.org/10.3390/cancers13153896